| Page 27 | Kisaco Research
 

Nicole Clouse

VP & Head of IP
Generate Biomedicines

Nicole Clouse

VP & Head of IP
Generate Biomedicines

Nicole Clouse

VP & Head of IP
Generate Biomedicines
 

Mark Didmon

Partner
Potter & Clarkson

Mark Didmon

Partner
Potter & Clarkson

Mark Didmon

Partner
Potter & Clarkson
 

Jason Murata

VP, IP
Alvotech

Jason Murata

VP, IP
Alvotech

Jason Murata

VP, IP
Alvotech
 

Jason Murata

VP, IP
Alvotech

Jason Murata

VP, IP
Alvotech

Jason Murata

VP, IP
Alvotech
 

Jason Murata

VP, IP
Alvotech

Jason Murata

VP, IP
Alvotech

Jason Murata

VP, IP
Alvotech
 

Dustin Edwards

Partner
Winston & Strawn

Dustin Edwards

Partner
Winston & Strawn

Dustin Edwards

Partner
Winston & Strawn
 

Catherine Pray

Senior Director
IntrepidEx

Catherine Pray

Senior Director
IntrepidEx

Catherine Pray

Senior Director
IntrepidEx

Discover how technology-forward innovation becomes commercial advantage. From selecting and integrating new technologies, to ensuring staff expertise and delivering personalized treatments - learn how to maximize outcomes, support recovery, and ensure robust ROI.

Author:

Nathan Lanham

Director of National Accounts
BTL Industries

Nathan Lanham

Director of National Accounts
BTL Industries

Author:

Benjamin Wood

Chief Medical Officer
Chapter Aesthetic Studio

Benjamin Wood

Chief Medical Officer
Chapter Aesthetic Studio

Author:

Sam Patel

Aesthetic Physician, Entrepreneur, Innovator, Consultant

Sam Patel

Aesthetic Physician, Entrepreneur, Innovator, Consultant
 

Sam Patel

Aesthetic Physician, Entrepreneur, Innovator, Consultant

Sam Patel

Aesthetic Physician, Entrepreneur, Innovator, Consultant

Sam Patel

Aesthetic Physician, Entrepreneur, Innovator, Consultant
 

Nathan Lanham

Director of National Accounts
BTL Industries

Nathan Lanham

Director of National Accounts
BTL Industries

Nathan Lanham

Director of National Accounts
BTL Industries